BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes ; volume:22 ; number:1 ; day:5 ; month:8 ; year:2023 ; pages:1-17 ; date:12.2023
Molecular cancer ; 22, Heft 1 (5.8.2023), 1-17, 12.2023
- Urheber
-
Yap, Jiajun
Yuan, Jimin
Ng, Wan Hwa
Chen, Gao Bin
Sim, Yuen Rong M.
Goh, Kah Chun
Teo, Joey
Lim, Trixie Y. H.
Goay, Shee Min
Teo, Jia Hao Jackie
Lao, Zhentang
Lam, Paula
Sabapathy, Kanaga
Hu, Jiancheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-023-01817-8
- URN
-
urn:nbn:de:101:1-2023110111133046298755
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yap, Jiajun
- Yuan, Jimin
- Ng, Wan Hwa
- Chen, Gao Bin
- Sim, Yuen Rong M.
- Goh, Kah Chun
- Teo, Joey
- Lim, Trixie Y. H.
- Goay, Shee Min
- Teo, Jia Hao Jackie
- Lao, Zhentang
- Lam, Paula
- Sabapathy, Kanaga
- Hu, Jiancheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
The prevalence of BRAF V600E mutation in hairy cell leukemia: A systematic review and meta-analysis study
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
The prevalence of BRAF V600E mutation in hairy cell leukemia: A systematic review and meta-analysis study
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation
Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia
The prevalence of BRAF V600E mutation in hairy cell leukemia: A systematic review and meta-analysis study
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer